Squarepoint Ops LLC Iterum Therapeutics PLC Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.19 - $0.36 $22 - $43	-120 Reduced 0.27%	44,442 $9,000
Q1 2022 May 16, 2022	SELL	$0.31 - $0.45 $1,550 - $2,251	-5,003 Reduced 10.09%	44,562 $16,000
Q4 2021 Feb 14, 2022	SELL	$0.39 - $0.74 $1,145 - $2,174	-2,938 Reduced 5.6%	49,565 $19,000
Q3 2021 Nov 15, 2021	BUY	$0.54 - $2.29 $14,645 - $62,107	27,121 Added 106.85%	52,503 $29,000
Q2 2021 Aug 16, 2021	SELL	$0.97 - $2.39 $24,069 - $59,305	-24,814 Reduced 49.43%	25,382 $59,000
Q1 2021 May 17, 2021	BUY	$0.97 - $2.73 $48,690 - $137,035	50,196 New	50,196 $71,000

145

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $21.2M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.